Cargando…

A Rare Case of Anaphylaxis to Methimazole in a Patient With Graves’ Disease

We present the case of a patient with Graves’ Disease (GD) who developed anaphylaxis to methimazole (MMI) necessitating hospitalization, emergent treatment and ultimately urgent total thyroidectomy. While the most common adverse reactions to thionamides include hepatotoxicity, agranulocytosis, pruri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garg, Dave, Garcia, Gonzalo Acosta, Praw, Stephanie Smooke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Thyroid
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090433/ http://dx.doi.org/10.1210/jendso/bvab048.1870

Ejemplares similares

FRI505 A Rare Case Of Methimazole Induced Grave Agranulocytosis
por: Barua, Nabonita, et al.
Publicado: (2023)

SAT-599 Propylthiouracil-Induced Anaphylaxis with Subsequent Tolerance of Methimazole
por: Liu, Angela, et al.
Publicado: (2019)

SUN-517 Methimazole-Induced Neutropenia in Premature Twins with Graves’ Disease
por: Ballestas, Estefania Rodriguez, et al.
Publicado: (2020)

THU669 Time To Achieve Euthyroidism In Graves Disease Using Methimazole In An Urban Population
por: Sultana Habbsa, Samima, et al.
Publicado: (2023)

Profound Hypothyroidism 21 Days After Methimazole Initiation in a Patient With Graves’s Disease and Liver Cirrhosis
por: Hammami, Safa, et al.
Publicado: (2021)

SAT-625 Dose-Dependent, Methimazole-Induced Agranulocytosis in a Pregnant Hispanic Woman with Grave's Disease
por: Bello, Fatimah, et al.
Publicado: (2019)

THU655 Methimazole Desensitization As An Effective Alternative To Ablation Therapy In Patients With Graves’ Disease Experiencing Thionamide-induced Type IV Hypersensitivity Reactions
por: Arguinchona, Joseph, et al.
Publicado: (2023)

SAT478 A Rare Case of Thyrotoxic Periodic Paralysis in a Patient with Concomitant Methimazole-Induced Agranulocytosis
por: Wei, Kevin S, et al.
Publicado: (2023)

Identification of RORg(+)T Cells as Key Players in Thyroid Autoimmunity From Checkpoint Immunotherapy
por: Lechner, Melissa G, et al.
Publicado: (2021)

SUN-572 Hyperthyroidism Refractory to Methimazole
por: Eren, Aysegul, et al.
Publicado: (2019)

Transdermal Absorption of Methimazole- a Cat’s Tale
por: Mittal, Ashima, et al.
Publicado: (2021)

A Case of Rare Autoimmune Pancytopenia Due to Graves’ Disease
por: Wang, Ally Wen, et al.
Publicado: (2021)

A Case Report on Methimazole-Induced Cholestatic Jaundice in an Elderly Man With Hyperthyroidism
por: Ng, Jennifer Lourdes, et al.
Publicado: (2021)

A Rare Case of Aggressive Ectopic Thyroid Cancer in a Patient With Graves Disease
por: Mahmood, Ejaz, et al.
Publicado: (2021)

LBODP100 A Rare Case Of Pembrolizumab Induced Graves’ Disease
por: Alqaisi, Sura, et al.
Publicado: (2022)

SUN-494 A Case of Hyperthyroidism with Multiple Recurrences of Neutropenia After Stopping Methimazole
por: Gil, Susana Mallea, et al.
Publicado: (2020)

PSAT239 Pregnant Patient With a History of Methimazole-Induced Agranulocytosis Presenting With Hyperthyroidism: A Case Report
por: Abduraup, Abdusattar, et al.
Publicado: (2022)

SUN-558 Methimazole Treatment of Thyrotoxicosis in the Setting of Ischemic Hepatitis
por: Chokshi, Sheel, et al.
Publicado: (2019)

FRI516 Low Dose Methimazole Induced Isolated Thrombocytopenia
por: Amer, Farah, et al.
Publicado: (2023)

Successful Management of Hyperthyroidism With Lithium and Radioiodine in a Patient With Previous Methimazole-Induced Agranulocytosis
por: Fantin, Esther H, et al.
Publicado: (2021)

A Rare Phenomenon of Hashimotos Thyroiditis Converting to Graves Disease
por: Caseja, Ahl Jeffrey, et al.
Publicado: (2021)

MON-439 Graves’ Disease and Papillary Thyroid Cancer: A Rare Clinical Case?
por: Volkova, Natalia, et al.
Publicado: (2020)

A Grave Initial Presentation of Graves’ Disease in a Patient With Moyamoya
por: Clutter, Courtney, et al.
Publicado: (2021)

SAT-600 Relapse of Agranulocytosis after Recovery of Methimazole-Induced Agranulocytosis
por: Choi, Dughyun, et al.
Publicado: (2019)

SUN-495 Rapid Resolution of Hyperthyroidism Induced Hepatic Dysfunction with Methimazole
por: Amir, Maryam, et al.
Publicado: (2020)

ODP496 Methimazole Induced Agranulocytosis Despite Minimal Intermittent Therapy
por: Uddin, Ashraf, et al.
Publicado: (2022)

PSAT344 Zeroing In: Methimazole Induced Agranulocytosis in Amiodarone Induced Thyrotoxicosis
por: Gunda, Mouna, et al.
Publicado: (2022)

A Grave Turn on Hashimoto’s Thyroiditis - A Case Series on Four Patients With Autoimmune Hypothyroidism that Converted to Grave’s Disease
por: Lee, Michelle N, et al.
Publicado: (2021)

SAT-471 A Rare Case of Pretibial Myxedema Preceding Graves’ Hyperthyroidism
por: Bao, Ginny W, et al.
Publicado: (2020)

PSAT296 Graves’ Disease and Hurthle Cell Carcinoma: A Rare Presentation
por: Bhatt, Plukshi J, et al.
Publicado: (2022)

Graves Disease in Infancy
por: Beliard, Kara A, et al.
Publicado: (2021)

ODP452 A Case of Thymic Hyperplasia in Graves’ Disease
por: Ahmed, Ammar, et al.
Publicado: (2022)

Graves’ Disease Induced Severe Hypercalcemia
por: Lugo Lopez, Zahira Marie, et al.
Publicado: (2021)

SUN-557 Thymic Hyperplasia in Graves' Disease: A Case Series
por: Voss, Michael, et al.
Publicado: (2019)

SUN-520 Graves Disease and T3 Thyrotoxicosis: A Case Report
por: thalambedu, Nishanth, et al.
Publicado: (2020)

PSAT340 Thymic Hyperplasia in Graves’ Disease: A Case Report
por: Gordon, Ashley, et al.
Publicado: (2022)

PSAT358 Graves’ Disease Complicated by Post-Operative Graves’ Ophthalmopathy and Pretibial Myxedema
por: Bowens, Brendan, et al.
Publicado: (2022)

SUN-524 Patient with Pseudohypoparathyroidism Type 1B, Graves Disease, and False Positive HIV Screen- a Rare Presentation
por: Desai, Viraj V, et al.
Publicado: (2020)

SAT474 A Case Report Of Moyamoya Disease Associated With Uncontrolled Graves' Disease
por: Tan, Zi, et al.
Publicado: (2023)

An Unusual Etiology of Graves’ Disease: Alemtuzumab
por: Santiago Carrion, Ada Marie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3av3shgcmsd2immqed5h035rb1